Skip to main content
. 2022 Mar 26;2022:9390539. doi: 10.1155/2022/9390539

Table 2.

Ovarian cancer cluster regions (OCCR) and breast cancer cluster regions (BCCR) in BRCA1 and BRCA2.

Gene #Bin No. of carriers Putative region Bin-starting nucleotide Bin-ending nucleotide Ratio (OR-breast: OR-ovarian) P value FDR P value
BRCA1 1 58 34 335 0.81 (0.45–1.47) 0.49 0.63
2 58 397 1115 0.78 (0.44–1.41) 0.4126 0.6189
3 63 OCCR1 1154 2111 0.29 (0.15–0.57) 0.0001539 0.0012186
4 58 2127 3229 1.07 (0.61–1.89) 0.8066 0.8066
5 62 3257 3771 0.78 (0.44–1.37) 0.3852 0.6189
6 59 3841 4573 0.88 (0.48–1.60) 0.6704 0.7542
7 58 4609 5095 1.65 (0.92–2.97) 0.09114 0.27342
8 59 5096 5468-1 1.46 (0.80–2.66) 0.2158 0.48555
9 66 BCCR1 5470 5524 3.12 (1.65–5.88) 0.0002708 0.0012186

BRCA2 1 41 BCCR2 10 2176 3.47 (1.51–7.96) 0.002485 0.012425
2 41 2244 4038 1.00 (0.47–2.14) 0.9981 0.9981
3 48 4151 5723 0.49 (0.23–1.04) 0.0603 0.1005
4 41 OCCR2 5745 7805 + 1 0.38 (0.16–0.86) 0.01789 0.044725
5 40 7835 10150 1.63 (0.73–3.62) 0.2281 0.285125

OR: odds ratio; FDR: false discovery rate.